Home > Insider Trading > Filing (0001654954-19-002991)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489798	Janet Dillione	C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-18	42,000	$1.67	180,909	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock	$0.00		4,213	4,213	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$1.66	2029-01-10	75,000	75,000	Direct
Common Stock	Phantom Stock	$0.00		6,637	6,637	Direct
Common Stock	Phantom Stock	$0.00		13,636	13,636	Direct
Common Stock	Phantom Stock	$0.00		37,500	37,500	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$0.57	2028-02-16	40,000	40,000	Direct
Common Stock	Phantom Stock	$0.00		13,392	13,392	Direct
Common Stock	Phantom Stock	$0.00		15,625	15,625	Direct
Common Stock	Phantom Stock	$0.00		20,833	20,833	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$2.24	2027-02-21	40,000	40,000	Direct
Common Stock	Phantom Stock	$0.00		3,472	3,472	Direct
Common Stock	Phantom Stock	$0.00		4,143	4,143	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$3.03	2025-08-11	50,000	50,000	Direct
Common Stock	Phantom Stock	$0.00		1,415	1,415	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$3.03	2026-02-21	95,000	95,000	Direct
Common Stock	Phantom Stock	$0.00		3,831	3,831	Direct
Common Stock	Phantom Stock	$0.00		2,767	2,767	Direct
Common Stock	Phantom Stock	$0.00		4,335	4,335	Direct
Common Stock	Phantom Stock	$0.00		15,306	15,306	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	4,213	4,213	Direct
2029-01-10	75,000	75,000	Direct
	6,637	6,637	Direct
	13,636	13,636	Direct
	37,500	37,500	Direct
2028-02-16	40,000	40,000	Direct
	13,392	13,392	Direct
	15,625	15,625	Direct
	20,833	20,833	Direct
2027-02-21	40,000	40,000	Direct
	3,472	3,472	Direct
	4,143	4,143	Direct
2025-08-11	50,000	50,000	Direct
	1,415	1,415	Direct
2026-02-21	95,000	95,000	Direct
	3,831	3,831	Direct
	2,767	2,767	Direct
	4,335	4,335	Direct
	15,306	15,306	Direct

Footnotes

Represents the weighted average purchase price of the shares purchased from a low of $1.655 to a high of $1.670 per share.
Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
These options were granted on 01/10/2019. The options vest monthly with 100% vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.